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Summary/Abstract: This chapter gives an overview of computational and mathematical 
modelling of the EGF receptor system. It begins with a survey of motivations for 
producing such models, then describes the main approaches that are taken to carrying out 
such modelling, viz. differential equations and individual-based modelling. Finally, a 
number of projects that applying modelling and simulation techniques to various aspects 
of the EGF receptor system are described.  














This paper gives an overview of computational models and simulations of the EGF 
receptor system; it is aimed at biologists who have no experience of such modelling and 
simulation techniques. It begins with a review of motivations for constructing such 
models, then surveys the kinds of models that can be built. Finally, a number of models 
of various parts of the EGF receptor system are described. 
2. Why Model and Simulate? 
By modelling we mean the construction of some computer program or mathematical 
description that describes some aspect of a system. Simulation is the running of a 
computer implementation of that model, i.e. setting parameters in, and the initial state of, 
a model, then modifying the state of that model a number of times to represent the system 
changing in time.  
 
There are a number of motivations for developing such models. At the simplest level, 
models can be used as informal tools to develop intuitions and ideas about the 
functioning of a system. By attempting to build a formal model that incorporates existing 
knowledge about the system, the less-well understood components of the system can 
become clearer; furthermore conjectures can be made, and tested for plausibility, about 
mechanisms that might explain those components. This process is, in general, referred to 
as synthetic biology. That is, it is an attempt to gain an understanding of a system by 
building it.  
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However, such a model cannot confirm anything positive about a system. Typically, it 
will be used to inspire further experimental work, by providing a prima facie case that 
some experiment might produce results of interest. Another function of such a system is 
to demonstrate that a particular mechanism cannot explain a particular behaviour, by 
showing that an implementation of that mechanism in simulation produces different 
behaviour (either at a qualitative or quantitative level) to an observed system.  
 
More formally, models can be used to integrate together a number of aspects of a system 
that are individually well-understood, yet where the interactions between those aspects 
are not. In such an approach, we build a number of computer programs or mathematical 
systems, each of which describes the individually well-understood subsystem and which 
has inputs and outputs that allow it to interact with other components of the system. 
Provided that such models are complete, and that their inclusion in a wider system does 
not produce additional effects or ill-understood non-linear interactions, such a system can 
produce accurate predictions about the behaviour of the system. Such an approach, 
however, is limited by our lack of such complete understanding of many biological 
systems (this is a situation which contrasts, for example, with models in physics, where 
many subsystems are well-understood). 
 
More rigorous uses of modelling and simulation will attempt to combine the model with 
experimental or observational data. In such an approach, the model typically represents a 
hypothesis about how the system works. Typically, a hypothesis is tested by ‘bringing the 
data to the hypothesis’; that is, data is measured, or transformed, so that it can be directly 
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compared with the hypothesis. Simulation can ‘take the hypothesis’ (part of the way) to 
the data”. A model is constructed, based on a hypothesis about the functioning of the 
system, and this model is then simulated by implementing it as a computer program and 
measuring those aspects of the simulation that correspond to the experimental data. These 
measurements can be compared to the experimental or observational data. 
 
There are a number of issues with this approach, two of which we shall explore. The first 
is that a typical model will have unknown parameters, which can affect both the 
qualitative and quantitative results that are measured. One approach to this issue is to use 
parameter fitting where the model is viewed as a parameterised space of models, and 
some optimization technique used to find a (heuristically) optimal setting for those 
parameters that maximises fit with the data.  One side benefit of this is that it gives an 
estimate for those parameters as part of the process; however, it should be noted that for 
many model/dataset pairs, many different possible parameter sets can give rise to 
behaviour compatible with the data. 
 
A final view of such models is that they represent hypothesis-driven combinations of 
attributes, which can be used as inputs to systems for prediction and classification 
problems. Typically, a statistical/computational model for prediction is produced by a 
supervised learning technique [Mitchell]. That is, we have a set of experimental or 
observational data, including one attribute of the system that we would like to be able to 
predict in the future (referred to as the class). For example, a medical dataset might 
consist of a list of patients: for each patient a list of symptoms is recorded, and an expert 
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diagnosis carried out. Supervised learning is any technique that takes such a dataset and 
produces a statistical/computational model that will make a prediction of the class; well 
known examples are naïve Bayes methods (see e.g. [2]) and decision tree induction [3]. 
In our example, the model would take a list of symptoms and make a diagnosis.  
 
Typically, such systems work using the raw data as inputs to the training process, that is, 
the process by which a generic predictive model is adjusted to generalise from the 
particular set of data being used. However, in some situations, constructed attributes can 
be used: that is, attributes from the data are combined to form new data attributes [4]. 
Typically, such constructions are simple and based on a basic search process for useful 
combinations. One way to view simulations is as hypothesis-driven attribute construction 
methods; that is, a simulation provides a new source of data for making predictions about 
a model, which is based on some hypothesis about the functioning of the system. In such 
a situation the final test of value is simply whether the addition of the new data source 
from the simulation adds to the accuracy of the simulation, measured on a previously 
unseen set of test data. 
3. Methods for Modelling and Simulation 
There are a number of methods for modelling and simulating cellular systems. In this 
section we discuss the various methods, focusing on differential equation-based and 
individual-based methods. 
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3.1 Differential Equation Methods 
One approach is to develop a set of differential equations that describe the system [5,6]. 
That is, the various interactions and reactions between entities in the system are described 
in terms of rates of exchange between different quantities (a classic example is the 
Michaelis-Menten equation for enzyme kinetics [7]). In such a system, when an amount 
of some substance is transformed in some way, the quantity of the original substance is 
reduced and that of the outcome of the transformation increased. So, for example, a 
phosphorylation event on molecule X would consist of reducing the amount of X in the 
system, and increasing the amount of phosphorylated-X. 
 
This is a powerful approach to modelling the basic levels of each substance of interest, 
and it has an advantage over some other methods in that many methods exist to get some 
analytic understanding of the problem (i.e. to understand some general properties and 
overall dynamics of the system) as well as to simulate it for a particular set of parameters 
and initial conditions.  
 
However, there are disadvantages to this kind of modelling. In particular, there are issues 
concerned with scaling and with representing space. Differential equation models 
provide a succinct summary of the interactions between a small number of molecule-
types. However, when a system contains many types of molecules, accounting for the 
different types whilst retaining a comprehensible model eventually becomes intractable. 
In terms of spatial distribution, differential equation models are better used when dealing 
with a small number of components where the free-mixing assumption can be made (i.e. 
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that any molecule can interact with any other). In systems where genuine spatial 
distribution is important, this can be modelled by partial differential equations; however, 
dealing with complex interactions between different molecule types across a space is 
difficult, and many of the mathematical techniques for getting a qualitative understanding 
of the model break down in such situations.  
3.2 Individual Based Methods 
The second main approach to modelling is individual-based modelling. In such a model, 
each entity in the system is represented by a separate entity in the computer; this contrasts 
with differential equation models, which keep track of aggregate counts of objects over 
time. This has a number of advantages: two of particular significance are that models of 
systems with many different kinds of components can be readily built, and that a full 
spatial model can be readily incorporated. 
 
In order to generate such a model, four aspects of the system need to be specified. Firstly, 
a list of the kinds of entities found in the system needs to be compiled. For a cell-biology 
model, these will typically be lists of molecules found in the system. Secondly, the kinds 
of interactions between those entities needs to be defined: most importantly, if two 
entities meet, do they bind? With what probability? Thirdly, the movement of the entities 
is defined: for example, Brownian motion, or flow through a region at a certain rate. 
Finally, a set of initial conditions needs to be specified. 
 
Commonly, not all of the information required to set up such a model is known in 
advance. As a result, a typical “model” is not a single model, but a parameterised space 
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of possible models: i.e. there are a number of unknown parameters in the model, and 
setting these parameters to a particular value specifies a particular model. Sometimes, 
such models can be used as part of a process to estimate the unknown parameters. For 
example, a model might represent a process that is too small to observe directly 
experimentally; however, this process might give rise to a phenomenon that can be 
directly observed. By finding a parameter setting within that space of models that 
reproduces the observed behaviour, we can conclude that the parameters (which will 
include properties of the unobservable behaviour) are a feasible set of parameters for the 
real system. 
 
Typically, this search through the parameter space will be carried out using some 
optimization heuristic [8], which will search for values of the parameters that maximize 
the fit between experimentally observable features of the system in simulation and in 
reality.  
 
An alternative approach is to use qualitative reasoning methods [9,10]. This approach 
consists of running a simulation using qualitative features about the objects in the 
simulation, rather than particular values: is a quantity positive or negative, is a 
relationship proportional, negative-proportional, threshold, et cetera? This can give a 
broad understanding of a model, even in the absence of concrete parameter settings. 
4. Implementing Individual Based Methods 
Individual based methods are typically implemented using an object-oriented 
programming technique [11] such as Java or C++. In order to create a program in such a 
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language, the programmer first creates types of objects known as classes, specifying the 
information that is stored within an object of that class and how objects of that class 
interact with other objects. The simulation then progresses by the creation and interaction 
of individual objects, each of which belongs to (and has its behaviour defined by) one of 
the classes. There are a number of different ways in which to manage the interactions 
between these objects; therefore the programmer of a simulation has to make a number of 
choices, before writing the simulation program. 
 
The first of these decisions is whether the model will be implemented in an event-based 
or timestep-based fashion. An event-based simulation [12] is one where the program 
maintains a list of events that change the state of the system, and the simulation is carried 
out by processing an event (such as an interaction between two molecules), calculating 
whether this generates any new events (e.g. a molecule dissociating from a complex, 
which might lead to a new interaction for that molecule), and then moving forward in 
time to the next event. This works well for systems where the “next event” can be readily 
calculated. However, in many biochemical models, this calculation is not easy due to 
processes such as Brownian motion, which can rapidly introduce a new potential 
interaction where there was none before. As a result, timestep-based methods, which 
move in a regular timestep and calculate all activity within that timestep, are commonly 
used in such situations. 
 
A second decision is the level of detail that the model will use. Different 
questions/hypotheses will require different levels of detail in the model. Ultimately, the 
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model needs to be a useful abstraction from reality—incorporating those features that are 
needed for the question at hand, whilst ignoring features that are irrelevant. There are also 
practical concerns in the decision. In particular, very detailed models can be time 
consuming to compute (up to the point where computation might be infeasible), or else 
not admit the kind of analytical techniques that can be used on simpler models. 
 
A third decision is whether the calculations will be stochastic (i.e. incorporating some 
randomness in the events) or deterministic. Given that all models at the cellular level will 
have some element of randomness in them when viewed at that level (Brownian motion 
and probability of two molecules binding being two examples), the stochastic modelling 
approach seems immediately more appropriate. However, when many objects are 
interacting, these individual interactions are often somewhat irrelevant. Instead, these 
large numbers of random events can be approximated by a deterministic rate of 
occurrence. Stochastic models are of most interest when the individual actions of 
molecules that exist in small numbers can have significant consequences for the system 
as a whole, as discussed by Andrews and Bray [13] and Lemerle et al. [14]. 
 
A final decision concerns how space is handled within the model. The simplest model of 
space is to assume that all of the components of the system interact within a single space: 
this is referred to as complete mixing. The next simplest model is that there are a number 
of components in the model (for example, within and outwith the cell) with some 
communication or exchange going on between these components, representing exchange 
of molecules between the domains or communication through transmembrane proteins. 
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Beyond this, we can develop models that have a spatial position for each component of 
the system: either represented as an approximation on a grid, or as a position given by 
decimal-number coordinates. This level of detail is important for some models (for 
example, studying the structure of receptor clusters or the formation of signalling 
complexes); however, for other models the complete mixing assumption is sufficient. 
5. Examples of Simulations 
Computational and mathematical models have been used for understanding a number of 
aspects of the EGF receptor system. Most simulations have concentrated on aspects of the 
intracellular signalling cascade; however, other approaches have addressed the 
oligomerisation behaviour on the cell surface.  As note by Gullick et al. [15,16], there are 
three main processes in the EGF receptor system. Firstly, the liganding of the 
extracellular domain, secondly, the dimerisation and oligomerisation of these receptors, 
and finally the intracellular signalling cascade set off by this dimerisation. The majority 
of effort in this area has focused on the intracellular signalling cascade, using differential 
equation models. This is where we begin our survey. Later in this section we discuss 
models of the cell-surface behaviour, integrated models that examine multiple stages, and 
systems that introduce formal languages for the description of interactions and which 
make steps toward integrating models into broader systems biology projects. 
5.1 Differential Equation Models of Intracellular Signalling Cascades 
The largest amount of work on simulation of the EGF receptor system has focused on 
differential equation models of the intracellular signalling cascade. These have been 
surveyed by Wiley et al. [17] and Orton et al. [18].  
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The core of such a model is a list of the various proteins involved in the signalling 
process, and a list of differential equations that specify the reaction rates between these 
proteins. These models are then simulated by the used of a numerical method, either from 
a generic mathematical software package such as Mathematica [19] or Matlab [20], or by 
software specifically designed for sets of biochemical interactions such as Gepasi [21]. 
 
The main parameters in such models are rate constants for the various reactions in the 
system. Typically these are derived from existing experimental work; if they are missing, 
a sensitivity analysis can sometimes be performed to check whether or not the particular 
value of the parameter is having a significant impact on the phenomenon of interest. 
 
A typical “experiment” using such a model will be to develop a model which introduces 
some new mechanism or interaction which, it is hypothesised, produces a particular 
experimentally-observed behaviour and therefore produces a viable hypothesis to explain 
the mechanism underlying that behaviour. In the remainder of this section we give a 
number of examples of such models. 
 
A detailed example of such a model is given by Suresh Babu et al. [22]. This paper 
begins by detailing a set of differential equations that represent the various reactions in 
the system. At the end of this process a parameterised space of models has been created, 
where the parameters represent the various rate constants for the reactions in the model. 
They then realise a particular model by inserting rate constants found in the literature. 
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They then test the accuracy of the model by a number of comparisons between 
experimental and computational work: plotting time-courses of Raf, MEK and ERK 
activation levels and comparing the latter two against Western blot analyses of wet lab 
experiments with the same setup; studying the effects of over-expression of proteins in 
the model and comparisons with known experimental effects of overexpression; studying 
time courses of phosphorylation and dephosphorylation; and, carrying out a sensitivity 
analysis of the system. This work shows that an accurate model of the cascade can be 
produced; however, they do not apply their simulation to testing any specific new 
hypotheses about the functioning of the system. 
 
One example of the application of computational methods to a specific problem in their 
area is the work of Brightman and Fell [23]. This paper describes a model of the MAP 
kinase cascade using the simulation system Gepasi [21], and applies this to form 
hypotheses for the difference in behaviour when the cascade is stimulated by EGF (in this 
case, the cascade is activated for a short time) and by NGF (in which case the cascade is 
stimulated for a sustained period of time). The simulation is used to narrow down where 
in the system a change will produce the effects seen in experimental work. In particular, 
it is shown that mechanisms that simply affect the intensity of signalling at the cell 
surface, or mechanisms that influence the phosphatase activity in the cascade are unlikely 
to produce the differences in effect observed in the experimental system. By contrast, 
their simulation of variations in the negative feedback regulation in the cascade do 
demonstrate a variety of differences in cascade persistence consistent with the 
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experimental observations. Therefore, they conclude that this final mechanism is the most 
likely candidate mechanism to explain the differences. 
 
Hendriks et al. [24] also apply simulations to help make a differentiation between two 
competing hypotheses to explain a particular observed phenomenon. The phenomenon is 
the localisation of dephosphorylation activity in the ErbB-triggered signalling cascade. 
They simulate two hypotheses concerning this: the first, that the activity is localised in 
the cell surface plasma membrane; the second, that intracellular, endosomal regions are 
the focus for it. By comparing these simulations against experimental data, they show 
that the former localisation is more likely to explain the observed phenomenon. 
 
Shvartsmann et al. [25] use a simulation to show that a proposed hypothesis is sufficient 
to explain an experimentally observed phenomenon. The phenomenon in question is the 
development of a single-peaked input into a pattern with two peaks; this is needed to 
show how the development of paired organs during development occurs. The 
computational model shows the ranges of parameters that would be required to generate 
the phenomenon in question: this could be seen as refinement of an initial qualitative 
hypothesis into more quantitative terms. Maly et al. [26] also carry out a simulation 
focused on feasibility. They demonstrate that a particular arrangements of feedback loops 
in an autocrine signalling system is capable of generating and maintaining cell polarity. 
5.2 Other Modelling Methods for the Intracellular Signalling Cascade 
Techniques other than differential equations have been used to model the signalling 
cascade. For example, Hlavacek et al. [27] have developed a system called BioGenNet 
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that is based on lists of rewriting rules: that is, rules that describe how parts of one 
structure can be transformed into another. This allows hierarchies of reaction rules to be 
created, rather than needing to specify each rule individually, as in the differential 
equation-based systems discussed above. In addition, such systems of rules permit new 
analytic methods such as model checking, which is a system for checking whether a set of 
rules is consistent with a formal description of how parts of a system will change with 
time.  
 
Blinov et al. [28] apply similar methods to reproduce and extend the earlier model of 
Kholodenko et al. [29], incorporating a larger number of reactions including proteins not 
incorporated into the Kholodenko model. 
 
Another method that has been used to model the signalling cascade is Petri nets [30]. 
This is a visually intuitive way of constructing and simulating systems, which can be 
readily visualised whilst the simulation is running. 
 
Schamel and Dick [31] have proposed an analogy between the signal transduction 
process and the Parallel Distributed Processing model used in modelling neural networks. 
However, this remains at the conceptual level rather than representing a way to 
implement simulations.  
 
An alternative approach to modelling is given by Pawson and Linding [32]. This takes an 
approach sometimes known as a synthetic biology approach to the problem. In this 
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approach, signalling networks are reverse engineered from known components. By 
carrying out such a reconstruction, the developer of the simulation is required to think 
carefully about the functional role of each of the components, and therefore develops a 
better understanding of the role that each component plays and the possible ways in 
which they can interact. 
6. Modelling Behaviour on the Cell Surface in the EGF Receptor System 
The process of dimerisation and higher-level clustering of EGF receptors on the cell 
surface is the subject of a paper by Goldman et al [33]. This consists of an object-oriented 
individual-based model, where receptors move under Brownian motion on a model of the 
cell surface, are able to be liganded, and which form clusters by binding with other 
receptors using a probabilistic model with parameters that can be specified by the user.  
 
A model using similar techniques has been developed to model the diffusion of ligands in 
the intercellular medium, and thus help to understand juxtacrine and paracrine signalling 
[34]. 
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6.1 Modelling the Overall System 
Recently, attempts have been made to combine models of various aspects of the system. 
For example, Hendriks et al. [35] have developed a differential equation model that 
combines a model of dimerisation of liganded receptors with a model of the consequent 
intracellular signalling cascade. This has been applied to model hypotheses concerning 
differences in the behaviour between ErbB1 receptors that are sensitive to the drug 
getfitinib (IRESSA), and those which are not. 
6.2 Higher Level Models for Intracellular Signalling Cascades 
Each piece of work described so far has consisted of a single modelling technique being 
applied to some particular problem. Recent papers by Calder et al. [18,36] takes a 
different approach. The approach taken is to describe the MAP kinase cascade in a 
mathematical language known as a process algebra. This is a formal description of the 
various interactions within the system. This high-level description can be automatically 
converted into both a deterministic, differential equation based system which can be 
simulated using numerical methods, and automatically converted into a stochastic model 
which can be simulated using an individual-based model. If the model is robust, both of 
these techniques should produce a similar outcome; however, sometimes artefacts from 
the particular simulation/numerical analysis method used can distort the solution.  
 
Calder et al. [36] use a comparison between the two models, derived from the process 
algebra description, to show such an artefact in the earlier paper of Schoberl et al. [37], 




Descriptions such as the process algebra have two main advantages. Firstly, they can be 
automatically converted into simulations of different types, thus showing up problems 
with a particular simulation technique for a particular problem. Secondly, they have the 
potential advantage that models can be analysed for qualitative features, as well as being 
converted into executable models. Some general issues concerned with models of this 
kind are discussed by Kolch et al. [38]. 
6.3 Integration with Larger System Biology Software Systems 
It has been noted by Hornberg et al. [39] that cancer is a canonical systems biology 
disease: if we want to understand cancer, we need to understand how information flows 
between many different parallel systems of chemical interactions. Other discussions of 
the impact of systems biology on signal transduction, are given by Citri and Yarden [40] 
and Suresh Babu et al. [41]. In recent years, attempts have been made to create software 
and description languages that allow the sharing and combining of models of biochemical 
systems. One of the most important of these languages is the Systems Biology Markup 
Language (SBML) [42]. The aim of this is to provide a common set of formal notation 
for the recording of diagrams of biochemical interactions, so that models can be shared 
between different software packages and combined into larger integrated models (for 
example the E-Cell project [43]). 
 
Recently, some early efforts have been made to give an SBML description of the EGF 
receptor system and its associated signalling cascade [44]. A more general discussion of 
this kind of notation is given by Kitano [45], Blinov [28], and Cary et al. [46]. 
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High-throughput techniques, such as microarrays, for data collection are often associated 
with systems biology approaches as they can provide the detailed data needed to 
complete a systems biology model. Studies such as that of Jones et al. [47] show how 
large scale protein networks can be studied and reaction rates quantified, which provide 
valuable input for simulations. 
7 Prospects 
Mathematical and computational models have proven useful in testing various hypotheses 
about the functioning of the EGF receptor system, and in providing a precise language for 
the expression of such hypotheses. In the future, we can see four new important 
directions for work of this type: 
• The use of such methods in combination with data gained from experiment. 
• The integration of these models into a wider set of tools for systems biology, 
leading to the integration of multiple models. 
• The use of languages to describe these systems that can be realised in a number of 
different ways, and have a number of different analytical tools applied to them. 
• The simulation of the activity of drugs on the system; and the use of 
computational search techniques to discover new targets for drug discovery (as 
illustrated by the work of Haugh et al. [48]). 
 
Breitling and Hoeller [49] also discuss future directions for such models. They outline 
four main directions for future applications of modelling of the EGF system: modelling 
of endosomal compartmentalisation, developing more sophisticated models of the protein 
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